Skip to Main Content

Paper Details

Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial.
Circulation
7
2021
Atrial Fibrillation, Edoxaban, Men, Myocardial Infarction, Women, alcohol, atrial fibrillation, coronary artery disease, diabetes, edoxaban, endogenous, endogenous factor Xa, factor Xa, hemorrhagic stroke, hypertension, intracranial bleeding, men, patients, renal dysfunction, stroke, systemic embolic events, warfarin, women
Author NameAffiliation
Elliott M AntmanBrigham and Women's Hospital, Harvard Medical School
Eugene BraunwaldBrigham and Women's Hospital, Harvard Medical School
Robert P GiuglianoBrigham and Women's Hospital, Harvard Medical School
Piera Angelica MerliniNiguarda Hospital
  • 1 - 4

Datasets

Release 1.2